Yahoo! Finance Search - Finance Home - Yahoo! - Help

Thursday, July 24 2014 2:37am ET - U.S. Markets open in 6 hours and 53 minutes.
Industry Center - Drug Manufacturers - Major
Industry Center > Drug Manufacturers - Major > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
· REIT - Retail
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Drug Manufacturers - Major News
Latest News
Thursday, Jul 24, 2014
·INNATE PHARMA : Completion of target enrollment in the phase II EffiKIR trial
GlobeNewswire - 1 hour, 0 minutes ago
Wednesday, Jul 23, 2014
·Merck & Co. Inc.: I'm Long, But It Screams Overvalued Today
at Seeking Alpha - Wed 10:15 pm ET
·Does The Eli Lilly Whisper Number Indicate Investor Confidence?
at Seeking Alpha - Wed 9:56 pm ET
·Gilead Stock's Great Expectations and Giant Opportunity
at Motley Fool - Wed 9:47 pm ET
·Glaxosmithkline Reports Weak Sales and Cuts Outlook
at The New York Times - Wed 9:00 pm ET
·Bristol-Myers Squibb and Ono Pharmaceutical Co., Ltd. Announce Strategic Immuno-Oncology Collaboration in Japan, South Korea and Taiwan
Business Wire - Wed 9:00 pm ET
·Platinum Delivers Letter To Echo Therapeutics, Inc. Demanding To Inspect Certain Books And Records Under Delaware Law
PR Newswire - Wed 7:44 pm ET
·Whisper Number Impact: What Will Bristol-Myers' Shares Do Post Earnings?
at Seeking Alpha - Wed 7:03 pm ET
·Correction: Blog points out Valeant's diverse portfolio is key to its success
at MarketWatch - Wed 6:10 pm ET
·Final Glance: Pharmaceuticals companies
AP - Wed 6:02 pm ET
·Sofinnova Ventures Raises $500M as Venture Capital Fundraising Rebounds
at The Wall Street Journal Online - Wed 5:54 pm ET
·Abuse of U.S. generic-drug rules costs billions -report
Reuters - Wed 5:12 pm ET
·Gilead Reports Strong Sales of Sovaldi, Putting It on Pace to Become a Blockbuster
at The New York Times - Wed 4:54 pm ET
·Biogen Stock's Tecfidera Embarrasses Wall Street
at Motley Fool - Wed 4:32 pm ET
·Is Inovio Undervalued After Positive HPV Therapy Results?
at Seeking Alpha - Wed 4:19 pm ET
·Puma Biotechnology Stock Shoves It in Short Sellers' Faces
at Motley Fool - Wed 4:02 pm ET
·Puma Biotechnology: Another Jackpot For Investors
at - Wed 3:31 pm ET
·Will Bristol-Myers Squibb (BMY) Disappoint This Earnings Season? - Wed 3:02 pm ET
·Surprise: The Real Costs Of Inversions Are Paid By Ordinary Shareholders
at Seeking Alpha - Wed 2:44 pm ET
·More Questions Raised About Boehringer Ingelheim's Pradaxa
at - Wed 2:18 pm ET
More Latest News...
Sponsor Results
17.2% 2013 Annuity Return
True Investor Returns with no Risk. Find out how with our Free Report.
6 Stocks to Hold Forever
These 6 stocks put your retirement portfolio ahead of the income game.
Top Medical Device Report
Top 50 Companies, Sizing, Growth, Trends, by Therapeutic Area
(What's This?)

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Manufacturers - Major Headlines
More Finance RSS Feeds

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?